Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for social cognition in adult men with schizophrenia
ACTRN12609000528257Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in schizophrenia (2 arms), sponsored by University of Sydney. Primary endpoint: Performance on Reading the Mind in the Eyes Test. Started Aug 2009; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ACTRN12609000528257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000528257.